Osteosarcoma usually exhibits a relatively low burden of SNVs, with few recurrent alterations in protein-coding genes beyond well-known tumor suppressors such as TP53 and RB1 [6,12,13,14]. This evidence concerns the gene RB1 and neoplasm.